MAHP 2020 Health Policy Speaker Series

Thank you to all who helped make the 2020 Speaker Series a great success!

Held virtually on November 6, November 20, and December 4, 2020

Speaker Series Videos

COVID-19 — Where Does the Nation Go from Here? — 11/20/20

COVID-19 Crisis – An Update from Massachusetts Leaders — 11/6/20

The 2020 Health Policy Speaker Series will take the place of MAHP’s annual conference this year. 

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions

Preti Strategies is an elite team of former lawmakers and experienced leaders in government relations, public affairs and communications. With offices in Massachusetts and New Hampshire, they have worked with clients to achieve goals nationwide.

Verrill provides a full spectrum of legal services to the varied organizations and individual professionals in the increasingly complex health care industry where organizations face emerging technologies, a broader than ever range of business issues, and intense government oversight.

Alnylam is leading the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to transform the lives of people with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system/ocular diseases.

Advisory Board helps health care leaders, including health plan executives, advance their organization’s strategic goals and navigate a rapidly changing environment through research-based insights, actionable strategies, and practical tools.

Agios Pharmaceuticals creates differentiated, small molecule medicines for patients in three focus areas – malignant hematology, solid tumors and rare genetic diseases – based on their unique expertise in cellular metabolism and adjacent areas of biology.

Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases.

HealthEdge is an agile and innovative solutions company focused on providing next-generation, business-transforming technology products to the healthcare payor market.

HMS advances healthcare by helping healthcare organizations reduce costs and improve health outcomes.

Massachusetts Association of Nurse Anesthetists (MANA) is a state association dedicated to the professional interests of certified registered nurse anesthetists (CRNAs).

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders.

Novo Nordisk makes innovative medicines to help people with diabetes manage their disease. The company’s ultimate goal is to defeat diabetes through prevention, detection and better management, and empower people with diabetes to live longer, healthier lives.

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.

MAHP 2020 Health Policy Speaker Series

Friday, November 6: COVID-19 Crisis – An Update from Massachusetts Leaders

9:00 a.m. – 9:30 a.m.

COVID-19 – Where Does Massachusetts Go from Here?

Marylou Sudders, MSW, ACSW, Secretary, Massachusetts Executive Office of Health & Human Services

9:30 a.m. – 10:00 a.m.

State of the State – A View from the Legislature

Robert A. DeLeo, Speaker, Massachusetts House of Representatives

Friday, November 20: COVID-19 — Where Does the Nation Go from Here?

9:00 a.m. – 10:00 a.m.

Dr. Ashish Jha, MD, Dean, Brown University School of Public Health

Friday, December 4: Election 2020 – What Does the Presidential Election Mean for Health Care Policy Going Forward?

9:00 a.m. – 10:00 a.m.

John McDonough, DrPH, MPA, Professor of Public Health Practice in the Department of Health Policy & Management, Harvard T.H. Chan School of Public Health

Avik Roy, President, Foundation for Research on Equal Opportunity & Policy Editor at Forbes

Moderator:  Jim Braude, Host, Greater Boston, GBH Channel 2; Co-Host, Boston Public Radio, GBH 89.7FM